A pragmatic randomized clinical trial of insulin glargine 300 U/
mL
vs first‐generation basal insulin analogues in insulin‐naïve adults with type 2 diabetes: 6‐month outcomes of the
ACHIEVE
Control study
Keyword(s):
Keyword(s):
Keyword(s):
2015 ◽
Vol 110
(2)
◽
pp. 158-165
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):